Search results for "Anemia"


 
Results 1 - 10 of about 286 for "Anemia".
Sort by: Relevance | Newest | Oldest

Antibiotic OKed for pneumonia, bloodstream, skin infections

In addition to approving ceftobiprole medocaril sodium for three different types of infection, the FDA authorized the first generic version of fidaxomicin, among other actions.
https://acphospitalist.acponline.org/archives/2024/04/10/antibiotic-oked-for-pneumonia-bloodstream-skin-infections.htm
10 Apr 2024

Disseminated varicella infection in an immunocompromised patient

A patient with a history of liver transplant presented with a progressive rash.
https://acphospitalist.acponline.org/archives/2024/04/03/free/disseminated-varicella-infection-in-an-immunocompromised-patient.htm
3 Apr 2024

Cases from the Medical College of Wisconsin

A mycotic aneurysm, retroperitoneal hematoma, and more.
https://acphospitalist.acponline.org/archives/2024/02/28/free/cases-from-the-medical-college-of-wisconsin.htm
28 Feb 2024

Babesiosis

An older patient with multiple comorbidities presented with headaches, fevers, myalgias, arthralgias, and some loss of balance.
https://acphospitalist.acponline.org/archives/2023/12/20/free/babesiosis.htm
20 Dec 2023

Surgical devices, ventilators, dialysis machines recalled

The FDA also approved first-time generics for spironolactone oral suspension and calcium gluconate, among other actions.
https://acphospitalist.acponline.org/archives/2023/11/15/surgical-devices-ventilators-dialysis-machines-recalled.htm
15 Nov 2023

No significant difference in outcomes with liberal, restrictive transfusion in acute MI

In a randomized trial of patients with acute myocardial infarction (MI) and anemia, a hemoglobin cutoff below 10 g/dL for transfusion was associated with an insignificant reduction in risk of MI or death at 30 days versus a cutoff of 7 or 8 g/dL.
https://acphospitalist.acponline.org/archives/2023/11/15/no-significant-difference-in-outcomes-with-liberal-restrictive-transfusion-in-acute-mi.htm
15 Nov 2023

New COVID-19 boosters, biosimilar for MS OK’ed

The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
https://acphospitalist.acponline.org/archives/2023/10/04/new-covid-19-boosters-biosimilar-for-ms-oked.htm
4 Oct 2023

Surgery for malignant small bowel obstruction did not reduce 90-day mortality

A comparison in which some patients with malignant small bowel obstruction were randomized and some chose between surgery and nonsurgical management found no difference in mortality between treatments, but surgery was associated with more symptom improvement.
https://acphospitalist.acponline.org/archives/2023/08/09/surgery-for-malignant-small-bowel-obstruction-did-not-reduce-90-day-mortality.htm
9 Aug 2023

EHR-based intervention reduced repetition of blood typing and screening

The weekly average rate of duplicate blood type-and-screen tests decreased by 48.7% after a best practice advisory was added to the electronic health record (EHR) in a large health system.
https://acphospitalist.acponline.org/archives/2023/07/19/ehr-based-intervention-reduced-repetition-of-blood-typing-and-screening.htm
19 Jul 2023

Myocardial infarction

Be sure to distinguish between type 1 and type 2 when documenting care for a patient with acute myocardial infarction.
https://acphospitalist.acponline.org/archives/2023/06/28/myocardial-infarction.htm
28 Jun 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next